NFE2L2 and lung cancer: In this regard, it has become evident that malignant cells benefit from having increased Nrf2 pathway activity: this was first observed in lung cancer [42], as well as subsequently in many other cancer types, such as pancreatic, ovarian, liver, and gallbladder cancers [43].